Published in Semin Respir Crit Care Med on March 23, 2012
Dexmedetomidine Attenuates Bilirubin-Induced Lung Alveolar Epithelial Cell Death In Vitro and In Vivo. Crit Care Med (2015) 0.93
Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects. World J Gastroenterol (2014) 0.88
Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium. J Pediatr (2014) 0.87
Intrapulmonary shunt confirmed by intracardiac echocardiography in the diagnosis of hepatopulmonary syndrome. Hepatology (2013) 0.87
Pathophysiology of lung injury induced by common bile duct ligation in mice. PLoS One (2014) 0.84
Cirrhotic Multiorgan Syndrome. Dig Dis Sci (2015) 0.82
Hypoxia among patients on the liver-transplant waiting list. Arq Bras Cir Dig (2014) 0.81
Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study. Can J Gastroenterol Hepatol (2015) 0.79
Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol (2014) 0.79
Cirrhosis and hepatopulmonary syndrome. World J Gastroenterol (2014) 0.77
The hepatopulmonary syndrome. Arq Bras Cir Dig (2014) 0.77
Hepatopulmonary syndrome: the role of intra-abdominal hypertension and a novel mouse model. Int J Clin Exp Pathol (2014) 0.77
Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest (2007) 3.22
Clinical risk factors for portopulmonary hypertension. Hepatology (2008) 2.62
Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med (2012) 2.33
Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates. Liver Transpl (2007) 2.13
Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology (2010) 1.60
Pulmonary complications in chronic liver disease. Hepatology (2014) 1.57
Health-related quality of life and survival in liver transplant candidates. Liver Transpl (2010) 1.55
Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology (2003) 1.46
The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States. Am J Gastroenterol (2002) 1.46
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med (2009) 1.44
Serial pulse oximetry in hepatopulmonary syndrome. Dig Dis Sci (2011) 1.44
Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol (2007) 1.43
Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl (2004) 1.42
The hepatopulmonary syndrome. J Hepatol (2006) 1.37
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35
Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology (2008) 1.23
Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol (2003) 1.23
The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology (2004) 1.21
Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin Gastroenterol Hepatol (2007) 1.17
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology (2014) 1.16
Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology (2003) 1.16
Low intensity shear stress increases endothelial ELR+ CXC chemokine production via a focal adhesion kinase-p38{beta} MAPK-NF-{kappa}B pathway. J Biol Chem (2008) 1.08
Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study. PLoS One (2011) 1.07
ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats. Am J Physiol Gastrointest Liver Physiol (2004) 1.06
Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World J Gastroenterol (2005) 1.05
Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. Gastroenterology (2005) 1.05
Pentoxifylline attenuation of experimental hepatopulmonary syndrome. J Appl Physiol (1985) (2006) 1.05
Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol (2012) 1.05
International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation (2016) 0.99
Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl (2002) 0.99
Garlic and its active metabolite allicin produce endothelium- and nitric oxide-dependent relaxation in rat pulmonary arteries. Clin Exp Pharmacol Physiol (2002) 0.96
Pilot study of pentoxifylline in hepatopulmonary syndrome. Liver Transpl (2008) 0.95
Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome. Gastroenterology (2005) 0.92
Risk of aspiration pneumonia in suspected variceal hemorrhage: the value of prophylactic endotracheal intubation prior to endoscopy. Dig Dis Sci (2007) 0.92
Portopulmonary hypertension. Clin Liver Dis (2006) 0.92
PNPLA3 polymorphisms and liver aminotransferase levels in a Mexican American population. Clin Invest Med (2012) 0.91
Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis: testing the current guidelines. Dig Liver Dis (2013) 0.91
The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. J Hepatol (2012) 0.91
Hepatopulmonary syndrome. Curr Treat Options Gastroenterol (2005) 0.88
Model for end-stage liver disease (MELD) exception for portopulmonary hypertension. Liver Transpl (2006) 0.87
Hepatopulmonary syndrome. Curr Opin Gastroenterol (2014) 0.87
Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats. Am J Physiol Gastrointest Liver Physiol (2009) 0.87
Hepatopulmonary syndrome. Clin Liver Dis (2005) 0.86
Pulmonary complications in cirrhosis. Curr Opin Organ Transplant (2011) 0.85
Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol (2002) 0.85
Developmental changes in circulating IL-8/CXCL8 isoforms in neonates. Cytokine (2009) 0.85
Hepatopulmonary syndrome: more than just a matter of tone? Hepatology (2006) 0.84
Serotonin transporter polymorphisms in patients with portopulmonary hypertension. Chest (2009) 0.83
Implementation of vaccination in patients with cirrhosis. Dig Dis Sci (2002) 0.82
Model for end-stage liver disease-based organ allocation: managing the exceptions to the rules. Clin Gastroenterol Hepatol (2013) 0.82
Hepatopulmonary syndrome. Liver Int (2004) 0.82
Pulmonary diseases and the liver. Clin Liver Dis (2011) 0.81
Population-based risk factors for elevated alanine aminotransferase in a South Texas Mexican-American population. Arch Med Res (2012) 0.80
Hepatopulmonary syndrome: a good relationship gone bad. Gastroenterology (2003) 0.80
Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation. J Appl Physiol (1985) (2004) 0.80
Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation. Liver Transpl (2008) 0.80
Gender preference for the endoscopist among Hispanics: the results of a prospective study. J Immigr Minor Health (2014) 0.80
Plasma levels of S100A4 in portopulmonary hypertension. Biomarkers (2009) 0.79
Oxygen desaturation during sleep in hepatopulmonary syndrome. Hepatology (2008) 0.78
Portopulmonary hypertension: new clinical insights and more questions on pathogenesis. Hepatology (2003) 0.78
Pulmonary complications of cirrhosis. Curr Gastroenterol Rep (2011) 0.78
Hepatitis A. Curr Treat Options Gastroenterol (2004) 0.78
Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited. World J Gastroenterol (2010) 0.77
The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome. Am J Physiol Gastrointest Liver Physiol (2013) 0.77
Activation of the mammalian target of rapamycin signaling pathway in hepatocellular carcinoma. Hepatology (2010) 0.77
Current use of hepatitis B immune globulin for prevention of de novo hepatitis B in recipients receiving anti-HBc-positive livers. Hepatol Int (2011) 0.76
Hepatopulmonary syndrome and liver transplantation: who, when, and where? Hepatology (2013) 0.76
The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. Liver Transpl (2014) 0.75
Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study. J Clin Gastroenterol (2016) 0.75
Endothelin-B receptor overexpression prevents hypoxic pulmonary hypertension in cirrhotic rats. Chest (2005) 0.75
Pulmonary and critical care considerations in hepatic disease. Semin Respir Crit Care Med (2012) 0.75
Muscle cramps in liver disease. Clin Gastroenterol Hepatol (2013) 0.75